The polymyxin resistance testing market size is projected to be worth US$ 122.0 million in 2023. The market is likely to surpass US$ 222.5 million by 2033 at a CAGR of 6.2% during the forecast period. The industry that develops, produces, and distributes tests and assays intended to identify and evaluate resistance to polymyxin antibiotics is referred to as the Polymyxin Resistance Testing Market. A class of antibiotics known as polymyxins is used to treat severe infections brought on by bacteria that are multidrug resistant, particularly Gram-negative bacteria.
Bacteria that have acquired genetic mutations or resistance genes that make them less vulnerable to or entirely resistant to the effects of polymyxin antibiotics develop polymyxin resistance. Testing for polymyxin resistance is performed to find these resistant bacteria and establish the best course of therapy.
Other Drivers Propelling the Demand for Polymyxin Resistance Testing include:
Challenges for Companies /Manufacturers in the Polymyxin Resistance Testing Market:
Opportunities in the Polymyxin Resistance Testing Industry:
Latest Trends in the Polymyxin Resistance Testing Market:
| Attributes | Details |
|---|---|
| Polymyxin Resistance Testing Market Size (2023) | US$ 122.0 million |
| Polymyxin Resistance Testing Market Projected Size (2033) | US$ 222.5 million |
| Value CAGR (2023 to 2033) | 6.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global polymyxin resistance testing market experienced a CAGR of 6.0%, reaching a market size of US$ 122.0 million in 2023.
From 2017 to 2022, As multidrug-resistant Gram-negative bacteria are becoming more common, polymyxin resistance has grown to be a serious issue in the field of antimicrobial resistance. The market's historical outlook shows that this issue has been acknowledged, and that there is a consequent need for efficient testing procedures to detect and control polymyxin resistance.
Future Forecast for Polymyxin Resistance Testing Industry:
Looking ahead, the global polymyxin resistance testing industry is expected to rise at a CAGR of 6.2% from 2023 to 2033 reaching valuation of US$ 222.5 million by the end of 2033. The rise in polymyxin-resistant bacterial infections, such as carbapenem-resistant Enterobacteriaceae (CRE) and multidrug-resistant Gram-negative bacteria, is expected to drive the demand for polymyxin resistance testing. As antimicrobial resistance becomes a global health concern, the need for accurate and timely testing to guide
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 56.1 million |
| CAGR % 2023 to End of Forecast (2033) | 6.2% |
The polymyxin resistance testing industry in the United States is expected to reach a market size of US$ 56.1 million by 2033, expanding at a CAGR of 6.2%. In order to reduce the risk of healthcare-associated infections (HAIs), infection control techniques have received a lot of attention in healthcare settings, including hospitals and long-term care facilities. Healthcare practitioners can implement effective infection control measures by using polymyxin resistance tests to identify patients who have been colonized or infected with polymyxin-resistant bacteria. Testing for polymyxin resistance is more popular due to rising infection control knowledge and emphasis.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 7.4 million |
| CAGR % 2023 to End of Forecast (2033) | 4.8% |
The polymyxin resistance testing industry in the United Kingdom is expected to reach a market value of US$ 7.4 million, expanding at a CAGR of 4.8% during the forecast period. The UK government has implemented various initiatives and policies to address the challenge of antibiotic resistance. These initiatives include the UK Five-Year Antimicrobial Resistance Strategy and the Antimicrobial Resistance (AMR) Action Plan. The government and regulatory bodies provide support and guidance for the development and implementation of accurate and reliable resistance testing methods, including polymyxin resistance testing. The supportive regulatory environment encourages market growth.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 19.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.5% |
The polymyxin resistance testing industry in China is anticipated to reach a market size of US$ 19.0 million, moving at a CAGR of 7.5% during the forecast period. China has been increasing its healthcare expenditure and focusing on the development of healthcare infrastructure. This includes the expansion and improvement of diagnostic facilities and laboratory capabilities. The investment in healthcare infrastructure supports the adoption of advanced testing methods, including polymyxin resistance testing, and contributes to market growth.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 13.3 million |
| CAGR % 2023 to End of Forecast (2033) | 7.1% |
The polymyxin resistance testing industry in Japan is estimated to reach a market size of US$ 13.3 million by 2033, thriving at a CAGR of 7.1%. Japan has a well-developed healthcare infrastructure, including sophisticated diagnostic facilities and laboratory capabilities. The availability of advanced technologies and equipment facilitates the adoption of cutting-edge diagnostic methods, including polymyxin resistance testing. The advanced healthcare infrastructure supports the growth of the market by enabling accurate and efficient testing.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 5.6 million |
| CAGR % 2023 to End of Forecast (2033) | 6.6% |
The polymyxin resistance testing industry in South Korea is expected to reach a market size of US$ 5.6 million, expanding at a CAGR of 6.6% during the forecast period. Research and development activities in the field of polymyxin resistance testing are promoted in South Korea through cooperative efforts between research institutions, healthcare organizations, and industry participants. Joint research projects seek to improve testing procedures, broaden the spectrum of observable resistance mechanisms, and increase data reporting and interpretation. The Polymyxin Resistance Testing Market in South Korea is expanding due to cooperative research and development initiatives.
Principal Consultant
The testing systems is expected to dominate the polymyxin resistance testing industry with a CAGR of 6.4% from 2023 to 2033. Testing systems are designed to detect the presence of specific resistance mechanisms or genes that confer resistance to polymyxin antibiotics. These systems employ various techniques, such as polymerase chain reaction (PCR), DNA sequencing, and phenotypic testing, to identify resistance in bacterial strains. Accurate and reliable detection of polymyxin resistance is essential for guiding appropriate treatment decisions and preventing the spread of resistant strains.
The Broth Microdilution (BMD) segments are expected to grow at significant rate due to its greater adoption as compared other testing methods within the polymyxin resistance testing industry with a CAGR of 7.0% from 2023 to 2033. Broth Microdilution (BMD) is a widely accepted and standardized method for testing bacterial susceptibility to antimicrobial agents, including polymyxins. It involves diluting antimicrobial agents in a liquid growth medium, inoculating bacterial strains, and measuring the minimum inhibitory concentration (MIC) of the drug required to inhibit bacterial growth. The standardized nature of BMD ensures consistent and reproducible results, making it a valuable tool for researchers, clinicians, and regulatory authorities.
The academic & research institutions segment is expected to dominate the polymyxin resistance testing industry with a CAGR of 7.0% from 2023 to 2033. Academic and research institutions play a vital role in the development and validation of testing methods for polymyxin resistance. They conduct extensive research to identify new resistance mechanisms, understand the genetic basis of resistance, and develop innovative testing approaches. This research contributes to the advancement of testing methods, enabling more accurate and reliable detection of polymyxin resistance.
The market for polymyxin resistance testing is highly competitive, with numerous businesses vying for supremacy. Important players must use cunning tactics in such a situation to stay ahead of the opposition.
Key Strategies Used by the Participants
To produce innovative goods that increase efficacy, dependability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
The polymyxin resistance testing sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the polymyxin resistance testing business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Polymyxin Resistance Testing Market:
In 2023, the market is likely to generate US$ 122 million revenue.
The market is poised to witness 6.2% CAGR through 2033.
The testing systems segment is poised to expand at 6.4% CAGR up till 2033.
The United States polymyxin resistance testing market could witness 6.2% CAGR until 2033.
Polymyxin resistance testing in China is poised to record a 7.5% CAGR through 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USPs 4.3. Technological Roadmap 4.4. Recent Product Approvals/Launches 4.5. Regulatory Landscape 4.6. PESTEL Analysis 4.7. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Increasing Cases of Bacterial Infections 5.2.3. Favourable Government Regulations 5.2.4. Technological Advancement in the Devices 5.2.5. Increasing Prevalence of Antimicrobial Resistance 5.2.6. Key Strategies by Manufacturers 5.2.7. Frequency of Product Approvals 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2017 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. Testing Systems 9.3.2. Test Kits & Identification Panels 9.3.3. Reagents & Consumables 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Testing Method 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Testing Method, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Testing Method, 2023 to 2033 10.3.1. Broth Microdilution (BMD) 10.3.2. Disk Diffusion 10.3.3. Etest (Broth Microdilution + Disk Diffusion) 10.3.4. Polymerase Chain Reaction (PCR) 10.4. Market Attractiveness Analysis By Testing Method 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 11.3.1. Clinical Laboratories 11.3.2. Academic & Research Institutions 11.3.3. Pharmaceutical/Biotech Companies 11.3.4. Food & Environmental Testing Laboratories 11.3.5. Veterinary Diagnostic Laboratories 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. USA 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Testing Method 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Testing Method 13.4.4. By End User 13.5. Country Level Analysis & Forecast 13.5.1. USA Market Analysis 13.5.1.1. .Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Product 13.5.1.2.2. By Testing Method 13.5.1.2.3. By End User 13.5.2. Canada Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Product 13.5.2.2.2. By Testing Method 13.5.2.2.3. By End User 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Testing Method 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Testing Method 14.4.4. By End User 14.5. Country Level Analysis & Forecast 14.5.1. Brazil Market Analysis 14.5.1.1. .Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Testing Method 14.5.1.2.3. By End User 14.5.2. Mexico Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Testing Method 14.5.2.2.3. By End User 14.5.3. Argentina Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Product 14.5.3.2.2. By Testing Method 14.5.3.2.3. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. France 15.3.1.3. Italy 15.3.1.4. UK 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Testing Method 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Testing Method 15.4.4. By End User 15.5. Country Level Analysis & Forecast 15.5.1. Germany Market Analysis 15.5.1.1. .Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Testing Method 15.5.1.2.3. By End User 15.5.2. France Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Testing Method 15.5.2.2.3. By End User 15.5.3. Italy Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Testing Method 15.5.3.2.3. By End User 15.5.4. UK Market Analysis 15.5.4.1. .Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Product 15.5.4.2.2. By Testing Method 15.5.4.2.3. By End User 15.5.5. Spain Market Analysis 15.5.5.1. .Introduction 15.5.5.2. Market Analysis and Forecast by Market Taxonomy 15.5.5.2.1. By Product 15.5.5.2.2. By Testing Method 15.5.5.2.3. By End User 15.5.6. Russia Market Analysis 15.5.6.1. .Introduction 15.5.6.2. Market Analysis and Forecast by Market Taxonomy 15.5.6.2.1. By Product 15.5.6.2.2. By Testing Method 15.5.6.2.3. By End User 15.5.7. BENELUX Market Analysis 15.5.7.1. .Introduction 15.5.7.2. Market Analysis and Forecast by Market Taxonomy 15.5.7.2.1. By Product 15.5.7.2.2. By Testing Method 15.5.7.2.3. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Testing Method 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Testing Method 16.4.4. By End User 16.5. Country Level Analysis & Forecast 16.5.1. India Market Analysis 16.5.1.1. .Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Testing Method 16.5.1.2.3. By End User 16.5.2. Thailand Market Analysis 16.5.2.1. .Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Testing Method 16.5.2.2.3. By End User 16.5.3. Indonesia Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Testing Method 16.5.3.2.3. By End User 16.5.4. Malaysia Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Testing Method 16.5.4.2.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Testing Method 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Testing Method 17.4.4. By End User 17.5. Country Level Analysis & Forecast 17.5.1. China Market Analysis 17.5.1.1. .Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Testing Method 17.5.1.2.3. By End User 17.5.2. Japan Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Testing Method 17.5.2.2.3. By End User 17.5.3. South Korea Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Testing Method 17.5.3.2.3. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Testing Method 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Testing Method 18.4.4. By End User 18.5. Country Level Analysis & Forecast 18.5.1. Australia Market Analysis 18.5.1.1. .Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Testing Method 18.5.1.2.3. By End User 18.5.2. New Zealand Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Testing Method 18.5.2.2.3. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. Northern Africa 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Testing Method 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Testing Method 19.4.4. By End User 19.5. Country Level Analysis & Forecast 19.5.1. GCC Countries Market Analysis 19.5.1.1. .Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Testing Method 19.5.1.2.3. By End User 19.5.2. Türkiye Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Testing Method 19.5.2.2.3. By End User 19.5.3. Northern Africa Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Product 19.5.3.2.2. By Testing Method 19.5.3.2.3. By End User 19.5.4. South Africa Market Analysis 19.5.4.1. Introduction 19.5.4.2. Market Analysis and Forecast by Market Taxonomy 19.5.4.2.1. By Product 19.5.4.2.2. By Testing Method 19.5.4.2.3. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Branding and Promotional Strategies, By Key Players 21.3. Key Development Analysis 21.4. Competition Deep Dive 21.4.1. Thermofisher Scientific 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. Sales Footprint 21.4.1.5. SWOT Analysis 21.4.1.6. Strategy Overview 21.4.1.6.1. Marketing Strategy 21.4.1.6.2. Product Strategy 21.4.1.6.3. Channel Strategy 21.4.2. Mast Group 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. Sales Footprint 21.4.2.5. SWOT Analysis 21.4.2.6. Strategy Overview 21.4.2.6.1. Marketing Strategy 21.4.2.6.2. Product Strategy 21.4.2.6.3. Channel Strategy 21.4.3. Liofilchem 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. Sales Footprint 21.4.3.5. SWOT Analysis 21.4.3.6. Strategy Overview 21.4.3.6.1. Marketing Strategy 21.4.3.6.2. Product Strategy 21.4.3.6.3. Channel Strategy 21.4.4. Rosco Diagnostica A/S 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. Sales Footprint 21.4.4.5. SWOT Analysis 21.4.4.6. Strategy Overview 21.4.4.6.1. Marketing Strategy 21.4.4.6.2. Product Strategy 21.4.4.6.3. Channel Strategy 21.4.5. bioMérieux SA 21.4.5.1. Overview 21.4.5.2. Product Portfolio 21.4.5.3. Key Financials 21.4.5.4. Sales Footprint 21.4.5.5. SWOT Analysis 21.4.5.6. Strategy Overview 21.4.5.6.1. Marketing Strategy 21.4.5.6.2. Product Strategy 21.4.5.6.3. Channel Strategy 21.4.6. Meridian 21.4.6.1. Overview 21.4.6.2. Product Portfolio 21.4.6.3. Key Financials 21.4.6.4. Sales Footprint 21.4.6.5. SWOT Analysis 21.4.6.6. Strategy Overview 21.4.6.6.1. Marketing Strategy 21.4.6.6.2. Product Strategy 21.4.6.6.3. Channel Strategy 21.4.7. Beckman Coulter 21.4.7.1. Overview 21.4.7.2. Product Portfolio 21.4.7.3. Key Financials 21.4.7.4. Sales Footprint 21.4.7.5. SWOT Analysis 21.4.7.6. Strategy Overview 21.4.7.6.1. Marketing Strategy 21.4.7.6.2. Product Strategy 21.4.7.6.3. Channel Strategy 21.4.8. Becton Dickenson & Company 21.4.8.1. Overview 21.4.8.2. Product Portfolio 21.4.8.3. Key Financials 21.4.8.4. Sales Footprint 21.4.8.5. SWOT Analysis 21.4.8.6. Strategy Overview 21.4.8.6.1. Marketing Strategy 21.4.8.6.2. Product Strategy 21.4.8.6.3. Channel Strategy 21.4.9. Accelerate Diagnostics, Inc. 21.4.9.1. Overview 21.4.9.2. Product Portfolio 21.4.9.3. Key Financials 21.4.9.4. Sales Footprint 21.4.9.5. SWOT Analysis 21.4.9.6. Strategy Overview 21.4.9.6.1. Marketing Strategy 21.4.9.6.2. Product Strategy 21.4.9.6.3. Channel Strategy 21.4.10. Bruker 21.4.10.1. Overview 21.4.10.2. Product Portfolio 21.4.10.3. Key Financials 21.4.10.4. Sales Footprint 21.4.10.5. SWOT Analysis 21.4.10.6. Strategy Overview 21.4.10.6.1. Marketing Strategy 21.4.10.6.2. Product Strategy 21.4.10.6.3. Channel Strategy 21.4.11. EUCAST 21.4.11.1. Overview 21.4.11.2. Product Portfolio 21.4.11.3. Key Financials 21.4.11.4. Sales Footprint 21.4.11.5. SWOT Analysis 21.4.11.6. Strategy Overview 21.4.11.6.1. Marketing Strategy 21.4.11.6.2. Product Strategy 21.4.11.6.3. Channel Strategy 21.4.12. Generon S.p.A. 21.4.12.1. Overview 21.4.12.2. Product Portfolio 21.4.12.3. Key Financials 21.4.12.4. Sales Footprint 21.4.12.5. SWOT Analysis 21.4.12.6. Strategy Overview 21.4.12.6.1. Marketing Strategy 21.4.12.6.2. Product Strategy 21.4.12.6.3. Channel Strategy 21.4.13. Bio-Rad Laboratories 21.4.13.1. Overview 21.4.13.2. Product Portfolio 21.4.13.3. Key Financials 21.4.13.4. Sales Footprint 21.4.13.5. SWOT Analysis 21.4.13.6. Strategy Overview 21.4.13.6.1. Marketing Strategy 21.4.13.6.2. Product Strategy 21.4.13.6.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Polymyxin Resistance Testing Market
